Literature DB >> 12060346

Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis.

Eileen H Bigio1, L S Hynan, E Sontag, S Satumtira, C L White.   

Abstract

In the past, 'Alzheimer disease' (AD) referred to pathologic AD with clinical onset of dementia in the presenium, while 'senile dementia of the Alzheimer type' (SDAT) referred to senile onset AD. Because AD appears clinically homogeneous regardless of age of onset, the two subtypes in more recent years have not been distinguished. Pathologic differences have been noted, but synapse loss has not previously been compared between the two groups. Hypothesizing that synapse loss would be greater in presenile onset than senile onset AD, we compared synapse loss, as well as Alzheimer pathology in presenile and senile onset AD, using an ELISA method to quantify synaptophysin. Synaptophysin was significantly lower in presenile than senile AD in right frontal and bilateral parietal lobes. Neuritic plaque counts were significantly higher in presenile than senile AD in bilateral frontal and parietal lobes. Semi-quantitative evaluation of neurofibrillary tangles revealed significantly more tangles in bilateral frontal and parietal lobes in presenile than senile AD. Brain weight was significantly lower in presenile than senile AD. The differences in synapse loss and Alzheimer-type pathology in presenile and senile onset AD support the hypothesis that 'cognitive reserve' protects the human brain from neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060346     DOI: 10.1046/j.1365-2990.2002.00385.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  26 in total

1.  Effects of age on the glucose metabolic changes in mild cognitive impairment.

Authors:  Kejal Kantarci; M L Senjem; V J Lowe; H J Wiste; S D Weigand; B J Kemp; A R Frank; M M Shiung; B F Boeve; D S Knopman; R C Petersen; C R Jack
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 2.  Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.

Authors:  Puneet Talwar; Juhi Sinha; Sandeep Grover; Chitra Rawat; Suman Kushwaha; Rachna Agarwal; Vibha Taneja; Ritushree Kukreti
Journal:  Mol Neurobiol       Date:  2015-09-09       Impact factor: 5.590

3.  Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold?

Authors:  Antonio Palasí; Belén Gutiérrez-Iglesias; Montse Alegret; Francesc Pujadas; Mikel Olabarrieta; Diana Liébana; Manolo Quintana; José Álvarez-Sabín; Mercè Boada
Journal:  J Neurol       Date:  2015-03-21       Impact factor: 4.849

4.  Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.

Authors:  Raffaella Migliaccio; Federica Agosta; Katherine L Possin; Elisa Canu; Massimo Filippi; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Differences between early and late onset Alzheimer's disease.

Authors:  Peter K Panegyres; Huei-Yang Chen
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

6.  Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders.

Authors:  Graziella Donatelli; Roberto Ceravolo; Daniela Frosini; Michela Tosetti; Ubaldo Bonuccelli; Mirco Cosottini
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-20       Impact factor: 5.081

Review 7.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

8.  Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum.

Authors:  R Migliaccio; F Agosta; K Rascovsky; A Karydas; S Bonasera; G D Rabinovici; B L Miller; M L Gorno-Tempini
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

9.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

10.  Multimodal Voxel-Based Meta-Analysis of White Matter Abnormalities in Alzheimer's Disease.

Authors:  Rui-Hua Yin; Lan Tan; Yong Liu; Wen-Ying Wang; Hui-Fu Wang; Teng Jiang; Joaquim Radua; Yu Zhang; Junling Gao; Elisa Canu; Raffaella Migliaccio; Massimo Filippi; Maria Luisa Gorno-Tempini; Jin-Tai Yu
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.